Surge announces closing of a €7.5 million fundraising round to decrypt the immune system and transform precision medicine
Surge has just closed its second round of funding, raising €7.5 million.
- Surge has just closed its second round of funding, raising €7.5 million.
- The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov’, as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé.
- The fundraising is complemented by grants from BPI, including support for deep tech development and the Future Investment Program, of which Surge was a laureate.
- This second round of funding, marked by the entry of strategic investors, reflects Surge's accelerated development and the beginning of the commercial expansion phase.